|
"lin yih jyh"的相關文件
顯示項目 1-25 / 43 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2023-4-29 |
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
|
郭欣瑜; Kuo, Shi-Yu; Wu, Juei-Seng;Hong, Tzu-Chun;Wu, Hung-Tsung;Lin, Yih-Jyh;Chang, Ting-Tsung;Wang, Chung-Teng;Liu, Wen-Chun;Hsieh, Ming-Tsung;Wu, I-Chin;Chen, Po-Jun;Chen, Chiung-Yu;Lin, Sheng-Hsiang;Chuang, Chiao-Hsiung;Han, Meng-Zhi;Chen, Huang-Pin;Tsai, Hong-Ming;Kuo, Hsin-Yu |
| 國立成功大學 |
2023-2 |
Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma
|
Chiang, Hsueh-Chien;Lee, Yang-Cheng;Chang, Ting-Tsung;Lin, Yih-Jyh;Wu, Hung-Tsung;Wang, Chung-Teng;Chen, Chiung-Yu;Chen, Po-Jun;Hsieh, Ming-Tsung;Lin, Sheng-Hsiang;Chen, Shang-Hung;Chuang, Chiao-Hsiung;Wu, I-Chin;Hong, Tzu-Chun;Wu, Juei-Seng;Han, Meng-Zhi;Chen, Wei-Ting;Chiang, Chien-Ming;Hung, Kuan-Kai;Kuo, Hsin-Yu; Kuo, Shi-Yu; 郭欣瑜 |
| 國立成功大學 |
2022-11 |
Real-world comparative effectiveness of nivolumab versus pembrolizumab in patients with unresectable hepatocellular carcinoma
|
郭欣瑜; Kuo, Shi-Yu; Kuo, Hsin-Yu;Han, Meng-Zhi;Liao, Chih-Hsiang;Lin, Yih-Jyh;Wang, Chung-Teng;Chen, Shang-Hung;Chang, Ting-Tsung;Chen, Po-Jun;Lin, Sheng-Hsiang;Chen, Chiung-Yu;Chuang, Chiao-Hsiung;Wu, I-Chin;Wu, Juei-Seng;Hong, Tzu-Chun;Hsieh, Ming-Tsung;Lee, Yang-Cheng;Wu, Hung-Tsung;Tsai, Hong-Ming |
| 嘉南藥理大學 |
2022 |
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
|
Kuo, Hsin-Yu; Han, Meng-Zhi; Liao, Chih-Hsiang; Lin, Yih-Jyh; Wang, Chung-Teng; Chen, Shang-Hung; Chang, Ting-Tsung; Chen, Po-Jun; Lin, Sheng-Hsiang; Chen, Chiung-Yu; Chuang, Chiao-Hsiung; Wu, I-Chin; Wu, Juei-Seng; Hong, Tzu-Chun; Hsieh, Ming-Tsung; Lee, Yang-Cheng; Wu, Hung-Tsung; Tsai, Hong-Ming |
| 國立成功大學 |
2021-7 |
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
|
郭欣瑜; Kuo, Shi-Yu; Tsai, Hong-Ming;Han, Meng-Zhi;Lin, Yih-Jyh;Chang, Ting-Tsung;Chen, Chiung-Yu;Cheng, Pin-Nan;Chuang, Chiao-Hsiung;Wu, I-Chin;Chen, Po-Jun;Kang, Jui-Wen;Chiu, Yen-Cheng;Chiu, Hung-Chih;Chien, Shih-Chieh;Kuo, Hsin-Yu |
| 臺大學術典藏 |
2021-07-15T05:31:54Z |
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives
|
Su, Yung Yeh; Li, Chia Chen; Lin, Yih Jyh; CHIUN HSU |
| 國立成功大學 |
2020-5-1 |
Impact of immune checkpoint inhibitors with or without a combination of tyrosine kinase inhibitors on organ-specific efficacy and macrovascular invasion in advanced hepatocellular carcinoma
|
Kuo, Hsin-Yu;Chiang, Nai-Jung;Chuang, Chiao-Hsiung;Chen, Chiung-Yu;Wu, I-Chin;Chang, Ting-Tsung;Tsai, Hong-Ming;Lin, Yih-Jyh; Kuo, Shi-Yu; 郭欣瑜 |
| 嘉南藥理大學 |
2020 |
Cancer-Derived Transforming Growth Factor-beta Modulates Tumor-Associated Macrophages in Ampullary Cancer
|
Cheng, Li-Chin; Chao, Ying-Jui; Wang, Chih-Yang; Phan, Nam Nhut; Chen, Yi-Ling; Wang, Tzu-Wen; Hsu, Hui-Ping; Lin, Yih-Jyh; Shan, Yan-Shen; Lai, Ming-Derg |
| 國立成功大學 |
2019-06-10 |
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma
|
林逢嘉; Lin, Forn-Chia; Pao, Tzu-Hui;Hsueh, Wei-Ting;Chang, Wei-Lun;Chiang, Nai-Jung;Lin, Yih-Jyh;Liu, Yi-Sheng |
| 臺大學術典藏 |
2018-09-10T14:57:15Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, C.-J. and Chang, J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, Y.-J. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Yang, M.-D. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; Liu, Chun-Jen;Chang, Juliana;Lee, Po-Huang;Lin, Deng-Yn;Wu, Cheng-Chung;Jeng, Long-Bin;Lin, Yih-Jyh;Mok, King-Tong;Lee, Wei-Chen;Yeh, Hong-Zen;Ho, Ming-Chih;Yang, Sheng-Shun;Yang, Mei-Due;Yu, Ming-Chin;Hu, Rey-Heng;Peng, Cheng-Yuan;Lai, Kuan-Lang;Chang, Stanley Shi-Chung;Chen, Pei-Jer; 胡瑞恒;劉俊人;陳培哲;李伯皇;何明志; MING-CHIH HO; Liu, Chun-Jen; Chang, Juliana; CHUN-JEN LIU; Lee, Po-Huang; PEI-JER CHEN; REY-HENG HU; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:14:11Z |
The binding affinity and molecular basis of the structure-binding relationship between urinary tamm-horsfall glycoprotein and tumor necrosis factor-α
|
Chang, Juliana; Li, Ko-Jen; Lee, Po-Huang; Siao, Sue-Cien; Siao, Sue-Cien; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Lin, Deng-Yn; Wu, Tsai-Hung; Wu, Cheng-Chung; Wu, Tsai-Hung; Jeng, Long-Bin; Tsai, Chang-Youh; Tsai, Chang-Youh; Lin, Yih-Jyh; Yu, Chia-Li; Yu, Chia-Li; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志; Wu, C.-H. and Li, K.-J. and Siao, S.-C. and Chen, Y.-H. and Wu, T.-H. and Tsai, C.-Y. and Yu, C.-L.; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; 余家利;吳政翰; Liu, Chun-Jen; Wu, Cheng-Han; CHENG-HAN WU; Wu, Cheng-Han; Li, Ko-Jen |
| 國立交通大學 |
2018-08-21T05:54:32Z |
Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus
|
Liu, Wen-Chun; Wu, I-Chin; Lee, Yen-Chien; Lin, Chih-Peng; Cheng, Ji-Hong; Lin, Yih-Jyh; Yen, Chia-Jui; Cheng, Pin-Nan; Li, Pei-Fu; Cheng, Yi-Ting; Cheng, Pei-Wen; Sun, Koun-Tem; Yan, Shu-Ling; Lin, Jia-Jhen; Yang, Jui-Chu; Chang, Kung-Chao; Ho, Cheng-Hsun; Tseng, Vincent S.; Chang, Bill Chia-Han; Wu, Jaw-Ching; Chang, Ting-Tsung |
| 國立成功大學 |
2016-08-02 |
Prediction of early hepatocellular carcinoma recurrence using germinal center kinase-like kinase
|
Ho, Cheng-Hsun; Chuang, Huai-Chia; Wu, I-Chin; Tsai, Hung-Wen; Lin, Yih-Jyh; Sun, Hung-Yu; Young, Kung-Chia; Chiu, Yen-Cheng; Cheng, Pin-Nan; Liu, Wen-Chun; Tan, Tse-Hua; Chang, Ting-Tsung |
| 國立成功大學 |
2016-08 |
Cost effectiveness of cancer treatment in Taiwan
|
Hung, Mei-Chuan; Lai, Wu-Wei; Chen, Helen H. W.; Lee, Jenq-Chang; Lin, Yih-Jyh; Hsiao, Jenn-Ren; Cheng, Ya-Min; Shan, Yan-Shen; Su, Wu-Chou; Wang, Jung-Der |
| 國立成功大學 |
2016-05-10 |
Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma
|
Tsai, Hung-Wen; Lin, Yih-Jyh; Wu, Han-Chieh; Chang, Ting-Tsung; Wu, I-Chin; Cheng, Pin-Nan; Yen, Chia-Jui; Chan, Shih-Huang; Huang, Wenya; Su, Ih-Jen |
| 國立成功大學 |
2015-04-24 |
Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade
|
Teng, Chiao-Fang; Hsieh, Wen-Chuan; Wu, Han-Chieh; Lin, Yih-Jyh; Tsai, Hung-Wen; Huang, Wenya; Su, Ih-Jen |
| 國立成功大學 |
2014-09 |
IL-20 and IL-20R1 Antibodies Protect Against Liver Fibrosis
|
Chiu, Yi-Shu; Wei, Chi-Chen; Lin, Yih-Jyh; Hsu, Yu-Hsiang; Chang, Ming-Shi |
| 國立成功大學 |
2014-09 |
MULTICENTRIC RETROPERITONEAL LEIOMYOSARCOMA WITH SATELLITE LESIONS NOT FOUND ON PET-CT: A CASE REPORT AND LITERATURE REVIEW
|
Hsieh, Chin-Chiang; Lin, Yih-Jyh; Huang, Kuo-Yuan |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立成功大學 |
2014-06 |
Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis
|
Wu, Han-Chieh; Tsai, Hung-Wen; Teng, Chiao-Fang; Hsieh, Wen-Chuan; Lin, Yih-Jyh; Wang, Lily Hui-Ching; Yuan, Quan; Su, Ih-Jen |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立成功大學 |
2013-11-14 |
Lin28B Is an Oncofetal Circulating Cancer Stem Cell-Like Marker Associate with Recurrence of Hepatocellular Carcinoma
|
Cheng, Shu-Wen; Tsai, Hung-Wen; Lin, Yih-Jyh; Cheng, Pin-Nan; Chang, Yu-Chung; Yen, Chia-Jui; Huang, Hsuan-Pang; Chuang, Yun-Pei; Chang, Ting-Tsung; Lee, Chung-Ta; Chao, Anning; Chou, Cheng-Yang; Chan, Shih-Huang; Chow, Nan-Haw; Ho, Chung-Liang |
| 國立成功大學 |
2013-09 |
Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients
|
Lin, Peng-Chan; Lin, Yih-Jyh; Lee, Chung-Ta; Liu, Hsiao-Sheng; Lee, Jenq-Chang |
| 國立成功大學 |
2013-06 |
SUMOylated CPAP is required for IKK-mediated NF-kappa B activation and enhances HBx-induced NF-kappa B signaling in HCC
|
Yang, Shu-Ting; Yen, Chia-Jui; Lai, Chien-Hsien; Lin, Yih-Jyh; Chang, Kung-Chao; Lee, Jenq-Chang; Liu, Yao-Wen; Chang-Liao, Pey-Yi; Hsu, Lu-Shin; Chang, Wen-Chang; Hung, Wen-Chun; Tang, Tang K.; Liu, Yi-Wen; Hung, Liang-Yi |
| 國立成功大學 |
2012-07-27 |
Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKK beta to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma
|
Yen, Chia-Jui; Lin, Yih-Jyh; Yen, Chia-Sheng; Tsai, Hung-Wen; Tsai, Ting-Fen; Chang, Kwang-Yu; Huang, Wei-Chien; Lin, Pin-Wen; Chiang, Chi-Wu; Chang, Ting-Tsung |
顯示項目 1-25 / 43 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
